Texaclear Fast Acting Allergy Relief Liquid
NDC Package 58809-360-08
Package Information
Texaclear Fast Acting Allergy Relief (chlophedianol hydrochloride, pyrilamine maleate) liquids is do not exceed recommended dosage.do not take more than 4 doses in any 24-hour period dose as follows or as directed by a doctor use enclosed dosing cupdo not use dosing cup with other products mL = milliliters adult and children 12 years and over30mL every 6-8 hourschildren under 12do not use. This formulation utilizes a liquid delivery system. Marketed by Gm Pharmaceuticals, Inc, this product is identified by NDC 58809-360 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2672917 - chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 30 mL Oral Solution
- RxCUI: 2672917 - chlophedianol hydrochloride 0.833 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution
- RxCUI: 2672917 - chlophedianol hydrochloride 12.5 MG / pyrilamine maleate 25 MG per 15 ML Oral Solution
- RxCUI: 2672917 - chlophedianol hydrochloride 25 MG / pyrilamine maleate 50 MG per 30 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58809 - Gm Pharmaceuticals, Inc
- 58809-360 - Texaclear Fast Acting Allergy Relief
- 58809-360-08 - 237 mL in 1 BOTTLE, PLASTIC
- 58809-360 - Texaclear Fast Acting Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58809-360-08 identifies a specific commercial package of 237 ml in 1 bottle, plastic of Texaclear Fast Acting Allergy Relief, a human over the counter drug labeled by Gm Pharmaceuticals, Inc. This liquid is formulated for oral use and contains chlophedianol hydrochloride; pyrilamine maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gm Pharmaceuticals, Inc on October 21, 2014. The current certification is valid through December 31, 2026.
How is this Gm Pharmaceuticals, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58809036008. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.